Presented at ECCMID, April 2022
Drew Lewis, Khurram Rana, Melissa Steidler, Gabrielle Poirier and David Altarac (ECCMID, 2022)
Program(s): durlobactam (etx2514)
John O'Donnell, Angela Tanudra, Sarah McLeod, Alita Miller and Ruben Tommasi (ECCMID, 2022)
Program(s): durlobactam (etx2514)
Alita Miller, Sarah McLeod, Daria Chabas, Gabrielle Poirier, and David Altarac (ECCMID, 2022)
Program(s): durlobactam (etx2514)
Khurram Rana, David Altarac, Robin Isaacs, Subasree Srinivasan, Sarah McLeod, Gabrielle Poirier, Andrew Shorr and Keith Kaye (ECCMID, 2022)
Program(s): durlobactam (etx2514)
Alita Miller, Sarah McLeod, Daria Chabas, Gabrielle Poirier and David Altarac (ECCMID, 2022)
Program(s): durlobactam (etx2514)
David Altarac, Robin Isaacs, Subasree Srinivasan, Sarah McLeod, Khurram Rana, Gabrielle Poirier, Andrew Shorr and Keith Kaye (ECCMID, 2022)
Program(s): durlobactam (etx2514)
Meredith Hackel, Sarah McLeod, Alita Miller and Daniel Sahm (ECCMID, 2022)
Program(s): durlobactam (etx2514)
Presented at SCI-RSC Symposium on Antimicrobial Drug Discovery, November 2021
Thomas Durand-Reville (SCI-RSC, 2021)
Program(s): etx0462
Presented at ECCMID, July 2021
Sarah McLeod, Samir Moussa, Meredith Hackel and Alita Miller (ECCMID, 2021)
Program(s): durlobactam (etx2514)